DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess
There is no Strong correlation between DNA methylation inhibitors and ADRs. Current comparative observational studies of these inhibitors show that there are common and specific adverse reactions in the ADR reports received by WHO for these drugs. Clinicians should improve the rational use of these drugs based on the characteristics of ADRs.
Authors
- Qian Guo (ORCID: https://orcid.org/0000-0002-1211-6436)
- Qiang Zhou (ORCID: https://orcid.org/0000-0002-7678-0563)
- Zhan Zhang (ORCID: https://orcid.org/0000-0002-9656-5721)
- Qiang Liu (ORCID: https://orcid.org/0000-0002-7668-6868)
- Jie Lin (ORCID: https://orcid.org/0000-0003-3535-5250)
- Haojie Wang (ORCID: https://orcid.org/0000-0001-6051-3076)
- Yu Zhao (ORCID: https://orcid.org/0000-0003-0831-3784)
- Quanlei Xie
Institutions
- Nanchang University (CN)
- Harbin Medical University (CN)
- Wenzhou Medical University (CN)
- Ruian People's Hospital (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.3389/fphar.2024.1470148
- Citations
- 8
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 3.64